天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

ChemicalBook Chinese Germany Japanese Korean

上海陶術(shù)生物科技股份有限公司 Company Information
Company Name:    TargetMol Chemicals Inc.
Tel:    -+1-781-999-5354;
Email:    marketing@targetmol.com
Nationality:    United States
WebSite:    https://www.targetmol.com/
Product List:    32376
152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256
Product List
NPS2390 226878-01-9
Spinorphin 137201-62-8
SEP-0372814 1516895-53-6
TC-I2000 1159996-20-9
Dantrolene 7261-97-4
QO-40 1259536-70-3
ZSET1446 887603-94-3
UNC1079 1418741-86-2
CNQX disodium 479347-85-8
DNQX disodium salt 1312992-24-7
SC-236 170569-86-5
Cysteine thiol probe 1947408-74-3
Butoconazole 64872-76-0
3-AQC 201216-42-4
Tenovin-6 Hydrochloride 1011301-29-3
SX-682 1648843-04-2
Vorolanib 1013920-15-4
IQ-3 312538-03-7
EIDD-1931 3258-02-4
TLR4-IN-C34 40592-88-9
3-Phenyl-N-[1-(phenylmethyl)-4-piperidinyl]-tricyclo[3.3.1.13,7]decane-1-carboxamide 1252187-41-9
VLX600 327031-55-0
SC-43 1400989-25-4
eCF506 1914078-41-3
Dabrafenib Mesylate 1195768-06-9
THIQ 312637-48-2
Vonafexor 1192171-69-9
MAZ51 163655-37-6
BMS-1001 2113650-03-4
Enoximone 77671-31-9
LQZ-7I 195822-23-2
RET V804M-IN-1 2414909-94-5
Empesertib 1443763-60-7
THPP-1 1257051-63-0
CB1 antagonist 4 1253641-65-4
ERK1/2 inhibitor 2 2095719-92-7
Ingliforib 186392-65-4
Ripretinib 1442472-39-0
BC-DXI-843 2421117-98-6
BMS-345541 hydrochloride 547757-23-3
Lenvatinib mesylate 857890-39-2
Masitinib mesylate 1048007-93-7
IM156 1422365-93-2
KN-92 hydrochloride 1431698-47-3
CPYPP 310460-39-0
WYC-210 2131803-93-3
AC1903 831234-13-0
m-3M3FBS 200933-14-8
ML382 1646499-97-9
SMCC 64987-85-5
Atezolizumab 1380723-44-3
Adalimumab 331731-18-1
RA-9 919091-63-7
Levomenol 23089-26-1
Tetrazole 27988-97-2
Metformin 657-24-9
ILK-IN-3 6975-75-3
Raphin1 acetate 2242616-04-0
Belinostat 866323-14-0
Bevacizumab 216974-75-3
Vanillic Acid 121-34-6
β-Caryophyllene 87-44-5
Filastatin 431996-53-1
Tyrphostin AG 112 144978-82-5
Avelumab 1537032-82-8
Cetuximab 205923-56-4
Rituximab 174722-31-7
Nivolumab 946414-94-4
Ustekinumab 815610-63-0
Vedolizumab 943609-66-3
Alirocumab 1245916-14-6
Daratumumab 945721-28-8
Denosumab 615258-40-7
Alemtuzumab 216503-57-0
Infliximab 170277-31-3
Pembrolizumab 1374853-91-4
Evolocumab 1256937-27-5
Trastuzumab 180288-69-1
Matuzumab 339186-68-4
Ipilimumab 477202-00-9
2-Pentylfuran 3777-69-3
Neryl acetate 141-12-8
Dehydroabietic acid 1740-19-8
Ramucirumab 947687-13-0
Pulegone 89-82-7
Cyclic AMP 60-92-4
trans-Benzylideneacetone 1896-62-4
5-Methylfurfural 620-02-0
2'-Hydroxyacetophenone 118-93-4
BENZYLACETONE 2550-26-7
Omalizumab 242138-07-4
Panitumumab 339177-26-3
Ofatumumab 679818-59-8
Obinutuzumab 949142-50-1
Nimotuzumab 828933-51-3
DihydroarteMisinic acid 85031-59-0
2-Phenylacetaldehyde 122-78-1
Yohimbine 146-48-5
2,5-Dihydroxyacetophenone 490-78-8
L-Alanine 56-41-7
152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256
Copyright 2007©  ChemicalBook. All rights reserved.